Eli Lilly and Company

Science has been our calling from the beginning. Colonel Eli Lilly founded the company in 1876 and charged employees to “take what you find here and make it better and better.” More than 147 years later, we remain committed to his vision through every aspect of our business and the people we serve, starting with discovering the best treatments for those who take our medicines and extending to health care professionals, employees and the communities in which we live. Moreover, you can also count on the team at Lilly to be incredibly civic-minded, supporting our communities through philanthropy, volunteerism, and a creative and innovative can-do spirit.

When you’re on a mission to do what’s never been done before, you seek people willing to challenge the status quo of medicine. Those willing to relentlessly pursue what’s next, all in the name of health above all. #WeAreLilly

893 S Delaware St
Indianapolis, IN 46285

Discovery is
in our DNA

Exceptional people with an
extraordinary purpose.
Our values and commitment
have guided our success
for over 140 years.

Explore Careers

We are Lilly

Why do our employees love coming to work each and every day? Here’s what they have to say.

“Opportunity for growth is actually the biggest reason that I ended up hiring into Lilly.”

Kavita - Associate Director, Packaging Operations
“Lilly worked bery hard to be able to allow me to settle into my role, but they also had a great deal of consideration for my life outside of work.”

Adrian - Associate Director, IDM
“What we do matters, it matters to the people that we interact with. It matters to people in our families and it matters to people around the world.”

Cecile - Sr Director, Design Hub Foundations

39,000 global employees coming together from diverse backgrounds to create medicines that make life better for people around the world. Get to know us through our Powered by Purpose series.

View Stories

NEWS

Policy

M&A May Be the Legacy of the Trump Tax Cuts for Pharma

Federal corporate tax cuts that were framed as a way to give a boost to employment across the United States have been more beneficial to companies and shareholders than the average worker or consumer, a new report issued by the advocacy group Americans for Tax Fairness shows.

January 8, 2019

3 min read

Alex Keown

Business

Day One of JPM Brings Excitement and Promise for a New Year in Biotech and Pharma

Biotech and pharma companies came roaring out of the gate on the first day of the annual J.P. Morgan Healthcare Conference with big deals, expansions and promises of growth and pipeline sustainability.

January 8, 2019

3 min read

Alex Keown

Deals

Eli Lilly Deepens Its Oncology Offerings With an $8 Billion Acquisition of Loxo Oncology

Eli Lilly and Company announced it was buying Loxo Oncology for $235 per share in cash, which comes to about $8 billion. The acquisition adds a lot of weight to Lilly’s oncology efforts.

January 7, 2019

3 min read

Mark Terry

Job Trends

Top 12 Life Sciences Companies Hiring Now in 2019

It’s a new year! Is one of your New Year’s resolutions to find a new job? Jump start your job search now and check out top companies who are looking for quality candidates in 2019!

January 4, 2019

1 min read

Editorial Staff

Eli Lilly Forecasts 10 Drugs Will Spur Revenue Growth in 2019

Those 10 drugs that were launched over the past five years are expected to account for more than 45 percent of human pharmaceutical sales in 2019, Joshua Smiley, Lilly’s chief financial officer said.

December 19, 2018

3 min read

Alex Keown

Drug Development

Eli Lilly’s Taltz Stands up to Humira in Psoriatic Arthritis Patients

At 24 weeks, the study met its primary endpoint. Lilly’s Taltz demonstrated superiority against AbbVie’s Humira, the best-selling drug in the world, in improving the signs and symptoms of active PsA.

December 17, 2018

2 min read

Alex Keown

Pharm Country

Readers’ Picks: Top 10 Stories of 2018

As we look back over the year, we noticed some stories just grabbed readers more than others. Here’s a look at the top 10 stories of the year, including job cuts, best-selling drugs, up-and-coming companies,scandals, clinical trials, and more.

December 13, 2018

5 min read

Mark Terry

Business

Lilly and AC Immune Sign Deal to Develop Tau-Based Treatments for Alzheimer’s

Eli Lilly and Company, headquartered in Indianapolis, and AC Immune SA, based in Lausanne, Switzerland, entered a license and collaboration deal to research and develop tau aggregation inhibitor compounds for the treatment of Alzheimer’s and other neurodegenerative diseases.

December 12, 2018

2 min read

Mark Terry

Drug Development

Top 9 Really Cool Life Science Discoveries of the Year

It seems like every time we turned around this year, there was an exciting or—on a more visceral level, “Hey, that’s cool!” science story. Here’s a look at the top 9 really cool life science discoveries of the year, from outer space, to peanut allergies, to tortoise genomes.

December 11, 2018

6 min read

Mark Terry

JOBS